BiotechTube

Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA

Phase 3Completed
1 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Post-Operative Pain

Conditions

Post-Operative Pain

Trial Timeline

Apr 1, 2012 → Dec 1, 2012

NCT ID
NCT01539538

About Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA

Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA is a phase 3 stage product being developed by Talphera for Post-Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01539538. Target conditions include Post-Operative Pain.

What happened to similar drugs?

4 of 11 similar drugs in Post-Operative Pain were approved

Approved (4) Terminated (0) Active (7)
🔄Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tabletJohnson & JohnsonPhase 3
🔄Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
🔄Comparator: MK0517 + Comparator: ondansetronMerckPhase 3
✅Sugammadex + Neostigmine + Atropine + Rocuronium + Fentanyl + Propofol + SevofluraneMerckApproved
✅granisetron + granisetronRocheApproved
✅Parecoxib SodiumPfizerApproved
🔄lyricaPfizerPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01539538Phase 3Completed

Competing Products

18 competing products in Post-Operative Pain

See all competitors
ProductCompanyStageHype Score
QutenzaAstellas PharmaPre-clinical
26
Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tabletJohnson & JohnsonPhase 3
40
Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
40
Paracetamol injection + Normal Saline injection + Morhpine PCAJiangsu Hengrui MedicinePhase 2/3
38
AGN-151607 + PlaceboAbbViePhase 2
35
Comparator: MK0517 + Comparator: ondansetronMerckPhase 3
40
Sugammadex + Neostigmine + Atropine + Rocuronium + Fentanyl + Propofol + SevofluraneMerckApproved
39
Aprepitant + Placebo to Aprepitant + Ondansetron + Placebo to match ondansetronMerckPhase 2
35
granisetron + granisetronRocheApproved
43
Parecoxib SodiumPfizerApproved
43
lyricaPfizerPhase 3
40
Placebo + Pregabalin + PregabalinPfizerPhase 1
29
Methylnaltrexone + PlaceboPfizerPhase 3
40
HSK16149 capsule + PlaceboHaisco Pharmaceutical GroupPhase 2
35
RopivacaineLundbeckApproved
40
Bupivacaine HCI without epinephrine + HTX-011Heron TherapeuticsPhase 2
25
Sufentanil NanoTab PCA System/15 mcg + Placebo Sufentanil NanoTab PCA SystemTalpheraPhase 3
30
Sufentanil Tablet 30 mcg + Placebo TabletTalpheraPhase 3
30